Stereotactic Body Radiotherapy Combined With PD-1 Blockers for Locally Advanced or Locally Recurrent Pancreatic Cancer

NCT06195254 · clinicaltrials.gov ↗

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Stereotactic Body Radiotherapy
PD-1 Inhibitors
Pancreatic Cancer

Interventions

RADIATION: Stereotactic body radiotherapy (SBRT)
DRUG: PD-1 blocking antibody

Sponsor

Peking University Third Hospital